Corrigendum to moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy Life Sci. 312 (2023)/121,210

Key Points

• This corrigendum addresses the effects of moxonidine on cardiac injury and its mechanisms related to autophagy in rats with metabolic syndrome.
• Experimental animal model using rats with induced metabolic syndrome
• Moxonidine treatment to assess cardiac injury and autophagy regulation
• Analysis of signaling pathways related to autophagy
• Moxonidine significantly reduced markers of cardiac injury compared to control group (p<0.01)
• Upregulation of autophagy-related proteins was observed in treated rats
• Improved cardiac function metrics were noted in moxonidine-treated rats, indicating therapeutic potential